GB1564458A - Pharmaceutical compositions containing montmorillonite derivatives - Google Patents

Pharmaceutical compositions containing montmorillonite derivatives Download PDF

Info

Publication number
GB1564458A
GB1564458A GB27708/77A GB2770877A GB1564458A GB 1564458 A GB1564458 A GB 1564458A GB 27708/77 A GB27708/77 A GB 27708/77A GB 2770877 A GB2770877 A GB 2770877A GB 1564458 A GB1564458 A GB 1564458A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
dimethyl
montmorillonite
weight
bentone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27708/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1564458A publication Critical patent/GB1564458A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB27708/77A 1976-07-01 1977-07-01 Pharmaceutical compositions containing montmorillonite derivatives Expired GB1564458A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7620143A FR2356425A1 (fr) 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite

Publications (1)

Publication Number Publication Date
GB1564458A true GB1564458A (en) 1980-04-10

Family

ID=9175127

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27708/77A Expired GB1564458A (en) 1976-07-01 1977-07-01 Pharmaceutical compositions containing montmorillonite derivatives

Country Status (10)

Country Link
US (1) US4096278A (OSRAM)
JP (1) JPS536410A (OSRAM)
AU (1) AU513829B2 (OSRAM)
BE (1) BE856319A (OSRAM)
CA (1) CA1103154A (OSRAM)
DE (1) DE2729824A1 (OSRAM)
FR (1) FR2356425A1 (OSRAM)
GB (1) GB1564458A (OSRAM)
NL (1) NL7707263A (OSRAM)
ZA (1) ZA773747B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
ATE226437T1 (de) * 1993-06-10 2002-11-15 Univ Wake Forest (phospho)lipide zum bekämpfen einer hepatitis b- infektion
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
EP0781138B1 (en) * 1994-08-29 2008-05-21 Wake Forest University Lipid analogs for treating viral infections
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
WO2002096826A2 (en) * 2001-05-29 2002-12-05 Koninklijke Philips Electronics N.V. Metal-ceramic bond
MXPA04001917A (es) * 2001-08-31 2004-06-15 Thomson Licensing Sa Contador de secuencia para una corriente audio-visual.
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
US20120058157A1 (en) * 2007-05-23 2012-03-08 Amcol International Corporation Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
US8481084B2 (en) * 2007-05-23 2013-07-09 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
CA2716835A1 (en) * 2008-02-27 2009-09-03 Amcol International Corporation Methods of treating cardiovascular disorders associated with atherosclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof

Also Published As

Publication number Publication date
FR2356425A1 (fr) 1978-01-27
US4096278A (en) 1978-06-20
CA1103154A (fr) 1981-06-16
ZA773747B (en) 1978-07-26
DE2729824A1 (de) 1978-01-05
NL7707263A (nl) 1978-01-03
AU2661577A (en) 1979-01-04
JPS536410A (en) 1978-01-20
BE856319A (fr) 1977-12-30
FR2356425B1 (OSRAM) 1978-12-15
AU513829B2 (en) 1981-01-08

Similar Documents

Publication Publication Date Title
GB1564458A (en) Pharmaceutical compositions containing montmorillonite derivatives
Becci et al. Short‐term toxicity studies of Sanguinarine and of two alkaloid extracts of Sanguinaria Canadensis L.
GB1579818A (en) Nifedipine-containing solid preparation composition
GB2139892A (en) Solid pharmaceutical preparation containing nifedipine
JPS62501908A (ja) 薬理的組成物及びそれを含有する薬理的製剤
GB2033225A (en) Orally administrable tablets
US4189469A (en) Pharmaceutical compositions
WO1999000122A1 (de) Verfahren zur reduktion des körpergewichtes
CA1216796A (en) Pharmaceutical compositions and preparation thereof
KR950002884B1 (ko) 아세트알데히드의 독성을 감소시키는 조성물
US2697059A (en) Hydroxy aromatic carboxylate-resin adsorption composition
US3144387A (en) Anti-inflammatory compositions
JPS6335635B2 (OSRAM)
US2841526A (en) Fatty acid-resin adsorption product
KR860006265A (ko) 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 제재의 제조방법
JPH03120257A (ja) 骨形成促進剤
US4840795A (en) Preparation and method for effecting fat and lipid adsorption
EP0190851A1 (en) Improved antiinflammatory composition
GB2051818A (en) Derivative of 1 ,25-dihydroxy-cholecalciferol
IE44763B1 (en) Ferrocene derivatives
US4311694A (en) Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials
EP0431759B1 (en) Process for the preparation of a ranitidine resin absorbate
US2914446A (en) Nitrite stabilized ascorbic acid-cyanocobalamin compositions
DE69635262T2 (de) Stabile pharmazeutische Zubereitung auf Basis von Acetylsalicylsäure und Tocopherol
DK164021B (da) Anvendelse af diltiazem til fremstilling af et farmaceutisk praeparat til behandling af hyperlipidemi

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee